Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Financial Ratios Markets  >  Corporate Information  >   Financial Ratios
Spacer
Concord Biotech Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
543960 INE338H01029 199.4246723 CONCORDBIO 0.61 12,866.75 43.29 28.41 1
Your Result on : Markets | Equity | Corporate Information | Financial Ratios
ParticularsMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Debt-Equity Ratio0.000.000.010.040.07
Long Term Debt-Equity Ratio0.000.000.000.020.04
Current Ratio3.803.743.212.953.44
Fixed Assets0.941.251.261.131.05
Inventory3.735.364.844.194.09
Debtors2.152.753.263.373.48
Interest Cover Ratio457.42477.80129.6862.7940.34
PBIDTM (%)40.4345.9445.8244.4541.71
PBITM (%)33.3841.4140.5538.1234.69
PBDTM (%)40.3545.8545.5143.8540.85
CPM (%)32.0035.6135.2434.2432.07
APATM (%)24.9531.0829.9727.9125.05
ROCE (%)18.3329.6228.8126.0521.86
RONW (%)13.7422.3521.6319.8516.95
Spacer